Biotechnology Market Developments and Forecast by 2025

[Research Report] The biotechnology market size was estimated to reach US$ 471,336.40 million by 2025 from US$ 218,012.10 million in 2017; it is estimated to grow at a CAGR of 10.5% during 2017-2025.

Market Insights and Analyst View:

Biotechnology is used in variety of applications that includes industrial/bio processing, bioinformatics, food & agriculture, health, natural resources & environment, and others.  In addition, the modern biotechnology enables to provide outstanding innovations for products and technologies against the unbearable and rare diseases it also reduces environmental footprint, feed the hungry. Furthermore, it utilizes less and cleaner energy for safer, cleaner and more efficient industrial manufacturing processes. Factors such as declining prices of genome sequencing, increasing innovative technologies bolstering the Biotechnology market growth. Additionally, increasing number of initiatives by private and government bodies are also driving the Biotechnology market growth. Moreover, rising Future conferences and workshops is expected to be the Biotechnology Market Trend in the future.        

Growth Drivers and Challenges:

The informatics experts and biologists using newer sequencing technologies by aiming at making better genomes. The improving software technologies for piecing DNA together and increasing novel techniques for locating sequences on chromosomes have risen in the recent years. To support the adoption of newer technologies with improved tools and techniques, several programs established. For instance, in 1989, the Genome Sequencing Program of the National Human Genome Research Institute (NHGRI) was established to address current scientific opportunities for Genomics.

The Genome Technology program is also supports to develop novel technologies with improved method and instruments that allow low-cost rapid determination of DNA sequence, functional genomics experiments and SNP genotyping. The Genome Technology program also supports the technology transfer from developers to the users and helps in promoting collaborative multidisciplinary programs that closely incorporate at industrial and academic laboratories. Moreover, many industry players have come up with innovative NGS technology in last few years. For instance, Pacific Biosciences with Sequel, and Oxford Nanopore with PromethION. Additionally, three advances NSG systems that dominate the market includes Roche GS FLX (454), Illumina HiSeq 2000 (Solexa) and AB SOLiD (Agencourt). Advancement in genome sequencing has made the sequencing easy and accurate.

Thus, due to the technological advancements the Biotechnology market is expected to grow at rapid pace.

Published Report - Biotechnology Market: Strategic Insights

Biotechnology Market Segmentation and Scope:

The “Global Biotechnology Market” is segmented based on technology, application, and geography. The Biotechnology market by technology is segmented into DNA sequencing, fermentation, cell based assay, nanobiotechnology, chromatography, PCR technology, tissue engineering and regeneration, other technologies. Based on application, the Biotechnology market is segmented into industrial processing, bioinformatics, food & agriculture, health, natural resources & environment, other applications. The Biotechnology market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)

Segmental Analysis:

Based on product, the Biotechnology market is segmented into DNA sequencing, fermentation, cell-based assay, nanobiotechnology, chromatography, PCR technology, tissue engineering and regeneration, other technologies. The DNA sequencing segment held the largest share of the market in 2017 and the same segment is likely to grow at a highest rate during the forecast period. DNA sequencing is the technique which is used to determine the specific order of the nucleotide bases that forms the strand of DNA. Currently it is an essential technique for the many of the basic and applied research studies and its applications. The technique of DNA sequencing was used in the human genome project which took thirteen years for its completion and helped to understand the cause of the genetic changes in the genetic diseases. The technique also helps to target the specific gene that can be used to design the drugs for the specific genetic disease. In addition, the DNA sequencing is used for the genetic testing for the paternity and other family relationship. Moreover, the DNA sequencing is used for the identifying the crime suspects and victims through the forensic studies. Furthermore, the techniques also have important role for analyzing the bacteria, and other microorganisms that are responsible for polluting air, water and food. DNA sequencing is majorly used to identify and study variations in different group of animals and plants and their migratory patterns for determining the rare breed for seed or livestock. Many companies like Thermo Fisher Scientific Inc., Merck KGaA, Illumina, Inc. and various other start-up companies offers various kits and reagents for the DNA sequencing technique. Thus, the advantages offered by DNA sequencing and their use in the above-mentioned applications are expected to robust the growth of the segment in the forecast period.

Based on application, the Biotechnology market is segmented into industrial processing, bioinformatics, food & agriculture, health, natural resources & environment, other applications. The industrial processing segment held the largest share of the market in 2017; whereas the bioinformatics segment is likely to grow at a higher rate during the forecast period. The industrial processing or the bioprocessing market is among the most promising field of the biotechnology that is impacting the healthcare, and agriculture biotechnology market significantly and also, it’s a new approach for the prevention of pollution and conserving the resources. The industrial processing or the bioprocessing market offers business that offers lower costs and create new market by disturbing the environment. Most of the lab studies in the biotechnology are taken out for the commercial applications. The applications are used for the drug discovery and the drug development. The developments for the therapeutics human proteins are done through the recombinant methods. For instance, recombinant human insulin is the first recombinant medicine produced and was marketed by Genetech in 1982. The rise in the prevalence of the diabetes have gained a huge profit for the recombinant insulin and have significant biotechnology market growth in future. Moreover, the application of industrial processing includes the production of enzymes and micro-organisms to make bio-based products in sectors such as chemicals, food ingredients, detergents, paper, textiles, beverages, fabrics, plastics, personal care, biofuels and more.

There is various process involved in the drug development process under the industrial processing. The steps such as discovery and development is the first step which is followed by the preclinical research, clinical research, FDA review and lastly the FDA post market safety monitoring. Many of the biopharmaceutical companies are involved in the process of drug development. The major product for the drug discovery and development is the protein which is offered by the various biotechnology companies. Many of the companies are involved in the expansion of the biopharmaceutical drugs that can be used to treat diseases like hepatitis, cancer and heart disease. The prevalence of the diseases is likely to enforce the biotechnology companies to produce more of the raw material required for the development of drug and thus, the companies are engaged in conducting the lab studies more aggressively. Therefore, considering the factors the application of the biotechnology for the industrial processing are likely to grow significantly in the coming near future. 

Regional Analysis:

Based on geography, the Biotechnology market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. In 2017, North America held the largest share of the global Biotechnology market, and Asia Pacific is estimated to register the highest CAGR during the forecast period. North America is largest market for biotechnology with the US holding the largest market share followed by Canada. The growth in North America is characterized by increase in the demand of innovative products from biopharmaceutical and biotechnology companies, presence of key market players and extensive R&D conducted by various academic and research institutes. Moreover, increasing focus on advanced method incorporation in healthcare, government and private initiatives for promotion of precision medicine and massive funds from government and private bodies for genomic research is further expected stimulate the growth and contribute to exceptional revenue generation for the biotechnology market in North America. The medical and agricultural biotechnology has undergone revolutions as a result of various development programs, business strategies that helps to produce, discover or alter various biomolecules and organisms through bioengineering approaches.

Further, the US biotechnology industry remains a global benchmark and is considered to be one of the fastest growing and successful market which is likely to maintain its position during the foreseeable future. Advances in science and technology as well as growing understanding of the underlying mechanisms are supporting development of new treatments for patients using biotechnological approaches in the US. The bionic eye, 3D printed organs, bioelectric cancer detection are few some of the major advances encountered by the country within the last few years in the field of biotechnology. Additionally, according to Journal of American Medical Association, the healthcare spending in the US is twice the rate of other high-income countries in the world.

The Biotech Startup Revolution has also assisted to promote the new ventures holding promising and innovative ideas in the region and supported in maximizing the revenue generation and thus the global economic position of North America in the global biotechnology market.     

Biotechnology

The regional trends and factors influencing the Published Report - Biotechnology Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Published Report - Biotechnology Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Published Report - Biotechnology Market Report Scope

Published Report - Biotechnology Market Players Density: Understanding Its Impact on Business Dynamics

The Published Report - Biotechnology Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Industry Developments and Future Opportunities: 

Various initiatives taken by key players operating in the global Biotechnology market are listed below:

1. In April 2022, CytoTronics raised US$9.25M in initial seed funding, led by Anzu Partners, with the association of Milad Alucozai (BoxOne Ventures) and institutional investors. The company will use this seed funding to promote its innovative platform that utilizes computer chip technology to conduct electrical and electrochemical cell-based assays.
2. In June 2021, Element Raised US$276 Million in Series C Financing for DNA Sequencing Platform. The sequencing platform is designed to lower the cost of genomic applications while materially enhancing quality by retooling a DNA sequencing system’s fundamental element, including sequencing chemistry, surface chemistry, detection, and data analysis for research and diagnostic users.
3. In February 2021, Selvita launched its new cell-based phenotypic assay platform for drug discovery. The Platform will be used to test new compounds with therapeutic potential in multiple areas, including neuroinflammatory, fibrotic diseases, and others, addressing specific constraints of existing therapeutic methods. The Platform will enable Selvita to complement its integrated drug discovery portfolio of services with a novel, powerful method to discover and develop new medicines quickly and effectively.  
4. In December 2021, Thermo Fisher Scientific Inc. announced that it had completed its acquisition of PPD, Inc., a leading global provider of clinical research services to the biopharma and biotech industry, for US$17.4 billion.

Covid-19 Impact:

The COVID-19 pandemic has positively impacted the biotechnology market. Companies are developing new treatment options for battling the COVID-19 outbreak. For instance, in December 2020, Thermo Fisher Scientific announced the CE-marking of its TaqPath COVID-19, Flu A/B, respiratory syncytial virus (RSV) Combo Kit for the in vitro diagnosis of SARS-CoV-2, RSV A/B infections, and influenza A/B.  

There is an increase in advancements and opportunities for drug development and manufacturing of vaccines for the COVID-19 infection. For instance, according to the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), over 11 billion doses of the COVID-19 vaccine were produced across the globe, resulting in the largest immunization program globally. Furthermore, the boom of mRNA vaccines and accelerated approval processes have led to an upsurge in vaccine-related revenues, as evident by a united revenue generation of about USD 31 billion in 2021 from Pfizer/BioNTech and Johnson & Johnson Moderna vaccines.  

Competitive Landscape and Key Companies:

Some of the prominent players operating in the global Biotechnology market include Thermo Fisher Scientific Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, PerkinElmer Inc., Danaher, QIAGEN, Agilent Technologies, BD, Bio-Rad Laboratories, Inc. and Illumina, Inc. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which provides them to serve a large set of customers and subsequently increases their market share.